	amyotrophic lateral sclerosis type 1	autosomal dominant centronuclear myopathy	autosomal dominant optic atrophy and cataract	L-2-hydroxyglutaric aciduria	"metaphyseal chondrodysplasia, Spahr type"	3-methylglutaconic aciduria type 3	autosomal recessive early-onset Parkinson disease 15	Sandhoff disease	neuronal ceroid lipofuscinosis 8	d-2-hydroxyglutaric aciduria	"spondyloepimetaphyseal dysplasia, Missouri type"	Alzheimer's disease 4	"Parkinson disease 11, autosomal dominant, susceptibility to"	neuronal ceroid lipofuscinosis 8 northern epilepsy variant	"Parkinson disease 13, autosomal dominant, susceptibility to"	"Microvascular complications of diabetes, susceptibility to, 6"	dilated cardiomyopathy 1V	"cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 4"	"coenzyme Q10 deficiency, primary, 8; COQ10D8"	Charcot-Marie-tooth disease axonal type 2CC	"3-methylglutaconic aciduria, type Viii; MGCA8"
musculoskeletal movement	0.0	1.0	1.0	0.0	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
lysosomal lumen acidification	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
negative regulation of transferase activity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
cellular protein metabolic process	0.0	0.0	0.0	1.0	1.0	0.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
